314 related articles for article (PubMed ID: 22155366)
21. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
[TBL] [Abstract][Full Text] [Related]
22. HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.
Gradilone SA; Habringer S; Masyuk TV; Howard BN; Masyuk AI; Larusso NF
Am J Pathol; 2014 Mar; 184(3):600-8. PubMed ID: 24434010
[TBL] [Abstract][Full Text] [Related]
23. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).
Banales JM; Masyuk TV; Gradilone SA; Masyuk AI; Medina JF; LaRusso NF
Hepatology; 2009 Jan; 49(1):160-74. PubMed ID: 19065671
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
Muff MA; Masyuk TV; Stroope AJ; Huang BQ; Splinter PL; Lee SO; Larusso NF
Lab Invest; 2006 Sep; 86(9):940-50. PubMed ID: 16783394
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases.
Urribarri AD; Munoz-Garrido P; Perugorria MJ; Erice O; Merino-Azpitarte M; Arbelaiz A; Lozano E; Hijona E; Jiménez-Agüero R; Fernandez-Barrena MG; Jimeno JP; Marzioni M; Marin JJ; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Banales JM
Gut; 2014 Oct; 63(10):1658-67. PubMed ID: 24436140
[TBL] [Abstract][Full Text] [Related]
26. Metformin slows liver cyst formation and fibrosis in experimental model of polycystic liver disease.
Sato Y; Qiu J; Hirose T; Miura T; Sato Y; Kohzuki M; Ito O
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G464-G473. PubMed ID: 33439105
[TBL] [Abstract][Full Text] [Related]
27. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.
Banales JM; Masyuk TV; Bogert PS; Huang BQ; Gradilone SA; Lee SO; Stroope AJ; Masyuk AI; Medina JF; LaRusso NF
Am J Pathol; 2008 Dec; 173(6):1637-46. PubMed ID: 18988797
[TBL] [Abstract][Full Text] [Related]
28. Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD.
Gradilone SA; Masyuk TV; Huang BQ; Banales JM; Lehmann GL; Radtke BN; Stroope A; Masyuk AI; Splinter PL; LaRusso NF
Gastroenterology; 2010 Jul; 139(1):304-14.e2. PubMed ID: 20399209
[TBL] [Abstract][Full Text] [Related]
29. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.
Masyuk TV; Huang BQ; Masyuk AI; Ritman EL; Torres VE; Wang X; Harris PC; Larusso NF
Am J Pathol; 2004 Nov; 165(5):1719-30. PubMed ID: 15509540
[TBL] [Abstract][Full Text] [Related]
30. Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.
Gallagher AR; Esquivel EL; Briere TS; Tian X; Mitobe M; Menezes LF; Markowitz GS; Jain D; Onuchic LF; Somlo S
Am J Pathol; 2008 Feb; 172(2):417-29. PubMed ID: 18202188
[TBL] [Abstract][Full Text] [Related]
31. Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney disease.
Williams SS; Cobo-Stark P; James LR; Somlo S; Igarashi P
Pediatr Nephrol; 2008 May; 23(5):733-41. PubMed ID: 18286309
[TBL] [Abstract][Full Text] [Related]
32. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
33. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.
Holditch SJ; Schreiber CA; Harris PC; LaRusso NF; Ramirez-Alvarado M; Cataliotti A; Torres VE; Ikeda Y
Kidney Int; 2017 Sep; 92(3):657-668. PubMed ID: 28416225
[TBL] [Abstract][Full Text] [Related]
34. Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models.
Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Santos-Laso A; Azkargorta M; Elortza F; Martinez-Chantar ML; Perugorria MJ; Aspichueta P; Marzioni M; LaRusso NF; Bujanda L; Drenth JPH; Banales JM
J Hepatol; 2021 Feb; 74(2):394-406. PubMed ID: 32950589
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
Sato Y; Harada K; Furubo S; Kizawa K; Sanzen T; Yasoshima M; Ozaki S; Isse K; Sasaki M; Nakanuma Y
Am J Pathol; 2006 Oct; 169(4):1238-50. PubMed ID: 17003482
[TBL] [Abstract][Full Text] [Related]
36. Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy.
Kelly KJ; Zhang J; Han L; Kamocka M; Miller C; Gattone VH; Dominguez JH
PLoS One; 2015; 10(7):e0131677. PubMed ID: 26136112
[TBL] [Abstract][Full Text] [Related]
37. A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation.
Woollard JR; Punyashtiti R; Richardson S; Masyuk TV; Whelan S; Huang BQ; Lager DJ; vanDeursen J; Torres VE; Gattone VH; LaRusso NF; Harris PC; Ward CJ
Kidney Int; 2007 Aug; 72(3):328-36. PubMed ID: 17519956
[TBL] [Abstract][Full Text] [Related]
38. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat.
Masyuk TV; Huang BQ; Ward CJ; Masyuk AI; Yuan D; Splinter PL; Punyashthiti R; Ritman EL; Torres VE; Harris PC; LaRusso NF
Gastroenterology; 2003 Nov; 125(5):1303-10. PubMed ID: 14598246
[TBL] [Abstract][Full Text] [Related]
39. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function.
Kim I; Fu Y; Hui K; Moeckel G; Mai W; Li C; Liang D; Zhao P; Ma J; Chen XZ; George AL; Coffey RJ; Feng ZP; Wu G
J Am Soc Nephrol; 2008 Mar; 19(3):455-68. PubMed ID: 18235088
[TBL] [Abstract][Full Text] [Related]
40. Feeding soy protein isolate and n-3 PUFA affects polycystic liver disease progression in a PCK rat model of autosomal polycystic kidney disease.
Maditz KH; Benedito VA; Oldaker C; Nanda N; Lateef SS; Livengood R; Tou JC
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):467-73. PubMed ID: 25822773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
